New medical technologies represented in specific companies recently added (September 2008) to the Medtech Startups Database:
Recombinant proteins and cells for intervertebral disc cell regeneration
Non-hydrogel polymer used to stimulate tissue growth in dental/orthopedic applications
Biomaterials and biologics for repair of bone and cartilage
Portable endoscopic imaging
Device treatments for restless leg syndrome (RLS)
Disposable steerable surgical instrumentation for arthroscopy
Technologies to [...]
Below is the coverage in the April 2008 issue of MedMarkets.
Ablation: An Energized Market
Demand for Hip and Knee Implants Expected to Increase
MedMarket Outlook: Beyond Technology Innovation: Current and Future Market Forces and Trends
Early Stage Companies: Evalve, ES Vascular, Cardiorobotics, TriVascular
Early Stage Company Financings: Alure Medical, Arbel Medical, Breathe Technologies, CoAxia, IDev Technologies, IlluminOss [...]
¶
Posted 13 May 2008
† P. Driscoll
§
biotech § cancer § cardiology § drug § innovation § market data § medtech § nanotech § neurology § obesity § ophthalmology § orthopedic § spine § startups § surgery § urogenital § wound management
‡
°
Tagged: biotech, cancer, cardiology, drug, innovation, market data, medtech, nanotech, neurology, obesity, ophthalmology, orthopedic, spine, startups, surgery, tissue engineering, urogenital, wound management
We have just updated our “High Growth Medical Technologies” white paper, as we expect to continually do in the immediate future, since the areas with growth keep changing, and new areas keep appearing.
As all white papers should be, it’s free. Here’s the link so you can download it.
bookmark to
¶
Posted 09 April 2008
† P. Driscoll
§
biotech § cancer § cardiology § drug § gastroenterology § innovation § market data § medtech § nanotech § neurology § obesity § ophthalmology § orthopedic § spine § startups § surgery § urogenital § wound management
‡
°
Tagged: biotech, cancer, cardiology, drug, gastroenterology, innovation, market data, medtech, nanotech, neurology, obesity, ophthalmology, orthopedic, spine, startups, surgery, tissue engineering, urogenital, wound management
(From the September 2007 issue of MedMarkets)
Drawing upon the clinical and technology sectors we have addressed in MedMarkets and the Market and Technology Reports of MedMarket Diligence, we have previously identified a number of areas where we see substantial growth in medical technology markets. In our white paper, High Growth Medical Technologies, we note those [...]
¶
Posted 26 September 2007
† P. Driscoll
§
biotech § cancer § cardiology § gastroenterology § market data § medtech § nanotech § neurology § obesity § orthopedic § surgery
‡
°
Tagged: biotech, cancer, cardiology, gastroenterology, market data, medtech, nanotech, neurology, obesity, orthopedic, surgery, tissue engineering
We analyze medical device markets and, by natural extention, markets encompassing devices or simply competing with them. We identify a specific disease or disorder, characterize its patient population, current and emerging trends in treatment and then characterize the markets for the products used. We may alternatively focus on an organ system (e.g., ophthalmology or a [...]
Not every start-up succeeds. But every single successful medical technology company was once a start-up. From a primary consideration, start-up companies have been founded based on: (1) what technologies they consider possible, and (2) the need for clinical solutions to problems that exist in health care. For this reason, we look at the range of [...]
¶
Posted 02 June 2007
† P. Driscoll
§
cancer § cardiology § medtech § nanotech § neurology § orthopedic § startups § surgery § urogenital § wound management
‡
°
Tagged: cancer, cardiology, medtech, nanotech, neurology, orthopedic, startups, surgery, tissue engineering, urogenital, wound management
The process of engineering tissues is advancing to the point where researchers actually consider such possibilities as organ printing. The formation of organs proceeds, at least in principle, on the formation of tubes, which then fuse after incubation in a bioreactor. It was described this way in Wired.Of course, organ complexity in terms of differentiated [...]
News came out last week (published in Lancet) on the successes achieved by well-known researcher Dr. Anthony Atala, professor at the Wake Forest Institute of Regenerative Medicine, in the development of pediatric bladders engineered from patients’ own cells.
The development of bioengineered organs, which faces many technological hurdles but also holds tremendous promise, was part of [...]
